MoonLake Immunotherapeutics (MLTX) Income Statement (2020 - 2026)
Income Statement report data from Sep 30, 2020 to Mar 31, 2026 for MoonLake Immunotherapeutics (MLTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | ||||||||||||||||||||
Research And Development | 55M (-2.66%) | 56M (-7.64%) | 61M (+21.86%) | 50M (+36.48%) | 36M (-9.66%) | 40M (+12.93%) | 36M (+51.06%) | 24M (+81.86%) | 13M (+60.62%) | 8.10M (+6.72%) | 7.59M (-12.76%) | 8.70M (+17.25%) | 7.42M (-33.57%) | 11M (+23.84%) | 9.02M (-20.88%) | 11M (+9.09%) | 10M (+1459.70%) | 670K | - | - |
Selling General And Administrative | 16M (+68.40%) | 9.21M (-14.72%) | 11M (-1.28%) | 11M (-0.82%) | 11M (+19.63%) | 9.22M (+24.93%) | 7.38M (+6.65%) | 6.92M (+1.62%) | 6.81M (-1.73%) | 6.93M (+28.57%) | 5.39M (+20.31%) | 4.48M (-18.84%) | 5.52M (-0.18%) | 5.53M (-3.83%) | 5.75M (-8.00%) | 6.25M (+13.84%) | 5.49M (-1.96%) | 5.60M (+6122.22%) | 90K (+800.00%) | 10K |
Operating Expenses | 70M (+7.36%) | 65M (-8.69%) | 71M (+17.68%) | 61M (+27.82%) | 47M (-4.22%) | 50M (+15.01%) | 43M (+40.97%) | 31M (+54.29%) | 20M (+31.87%) | 15M (+15.79%) | 13M (-1.59%) | 13M (+2.01%) | 13M (-22.57%) | 17M (+13.07%) | 15M (-16.32%) | 18M (+10.73%) | 16M (+154.23%) | 6.27M (+6866.67%) | 90K (+800.00%) | 10K |
Depreciation And Amortization | 850K (-62.05%) | 2.24M | - | - | 380K (-64.15%) | 1.06M | - | - | 330K (-10.81%) | 370K | - | - | - | 160K | - | - | - | - | - | - |
Operating Income | ||||||||||||||||||||
Operating Income | -70.02M (+7.36%) | -65.22M (-8.69%) | -71.43M (+17.68%) | -60.70M (+27.84%) | -47.48M (-4.24%) | -49.58M (+15.01%) | -43.11M (+40.97%) | -30.58M (+54.29%) | -19.82M (+31.87%) | -15.03M (+15.79%) | -12.98M (-1.59%) | -13.19M (+2.01%) | -12.93M (-22.57%) | -16.70M (+13.07%) | -14.77M (-16.32%) | -17.65M (+10.73%) | -15.94M (+154.23%) | -6.27M (+6866.67%) | -90.00K | - |
Ebit | -70.02M (+7.36%) | -65.22M (-8.69%) | -71.43M (+17.68%) | -60.70M (+27.84%) | -47.48M (-4.24%) | -49.58M (+15.01%) | -43.11M (+40.97%) | -30.58M (+54.29%) | -19.82M (+31.87%) | -15.03M (+15.79%) | -12.98M (-1.59%) | -13.19M (+2.01%) | -12.93M (-22.57%) | -16.70M (+13.07%) | -14.77M (-16.32%) | -17.65M (+10.73%) | -15.94M (+154.23%) | -6.27M (+6866.67%) | -90.00K | - |
EBITDA | -69.18M (-8.50%) | -75.61M (+13.84%) | -66.42M (+25.11%) | -53.09M (+12.69%) | -47.11M (-24.90%) | -62.73M (+77.71%) | -35.30M (+45.93%) | -24.19M (+24.11%) | -19.49M (-8.50%) | -21.30M (+126.60%) | -9.40M (-7.21%) | -10.13M (-21.66%) | -12.93M (-51.65%) | -26.74M (+164.75%) | -10.10M (-16.60%) | -12.11M (-24.03%) | -15.94M (+153.42%) | -6.29M (+7762.50%) | -80.00K | - |
Other Income / Expenses | ||||||||||||||||||||
Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | -10.00K | - | - | 10K | - | 20K | - |
Interest Expense | 2.27M (+13.50%) | 2.00M (-37.50%) | 3.20M (+56.86%) | 2.04M (+10100.00%) | 20K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | -10.00K | - | - | 10K | - | 20K | - |
Other Non Operating Income | - | - | - | - | - | - | - | - | - | - | 1.39M (+65.48%) | 840K (+16.67%) | 720K (+22.03%) | 590K (+1375.00%) | 40K (-84.00%) | 250K (+257.14%) | 70K | -20.00K | 20K | - |
Net Income | ||||||||||||||||||||
Income Before Tax | - | -229.71M | - | - | - | -120.96M | - | - | - | -43.98M | - | - | - | -64.47M | - | - | - | - | - | - |
Income Tax Expense | 620K (+148.00%) | 250K (+108.33%) | 120K (+20.00%) | 100K (-33.33%) | 150K (+275.00%) | 40K (-55.56%) | 90K (+12.50%) | 80K (+14.29%) | 70K (+75.00%) | 40K (+33.33%) | 30K (+200.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - |
Net Income From Continuing Operations | -69.71M (+11.68%) | -62.42M (-10.48%) | -69.73M (+26.28%) | -55.22M (+38.26%) | -39.94M (-12.43%) | -45.61M (+28.88%) | -35.39M (+45.82%) | -24.27M (+77.54%) | -13.67M (+83.74%) | -7.44M (-21.10%) | -9.43M (-7.00%) | -10.14M (+12.67%) | -9.00M (-24.11%) | -11.86M (+17.31%) | -10.11M (-16.58%) | -12.12M (-23.68%) | -15.88M (+152.46%) | -6.29M (+7762.50%) | -80.00K | - |
Net Income | -69.71M (+11.68%) | -62.42M (-10.48%) | -69.73M (+26.28%) | -55.22M (+38.26%) | -39.94M (-12.43%) | -45.61M (+28.88%) | -35.39M (+45.82%) | -24.27M (+77.54%) | -13.67M (+83.74%) | -7.44M (-21.10%) | -9.43M (-7.00%) | -10.14M (+12.67%) | -9.00M (-24.11%) | -11.86M (+17.31%) | -10.11M (-16.58%) | -12.12M (-23.68%) | -15.88M (+152.46%) | -6.29M (+7762.50%) | -80.00K | - |
Comprehensive Income Net Of Tax | -69.99M (-69.80%) | -231.73M (+231.18%) | -69.97M (+22.56%) | -57.09M (+34.14%) | -42.56M (-63.43%) | -116.38M (+224.90%) | -35.82M (+51.14%) | -23.70M (+76.60%) | -13.42M (-61.11%) | -34.51M (+423.67%) | -6.59M (-37.18%) | -10.49M (+16.30%) | -9.02M (-81.76%) | -49.44M (+394.40%) | -10.00M (-17.01%) | -12.05M (-22.81%) | -15.61M (+148.17%) | -6.29M | - | - |